Type1Diabetes IsAssociatedWith an Increased Risk of Fracture Across theLifeSpan:APopulation- Based Cohort Study Using The Health Improvement Network (THIN)

Diabetes Care

Volumn 38, Issue 10, 2015, Pages 1913-1920

  Weber, David R ^a   Haynes, Kevin ^b   Leonard, Mary B ^c   Willi, Steven M ^b   Denburg, Michelle R ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANKLE FRACTURE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMUR FRACTURE; FOOT FRACTURE; FRACTURE; HAZARD RATIO; HIP FRACTURE; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LEG FRACTURE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; UNITED KINGDOM; COMPLICATION; DIABETES MELLITUS, TYPE 1; FRACTURES, SPONTANEOUS; HIP FRACTURES; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; SEX RATIO; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EPIDEMIOLOGIC METHODS; FEMALE; FRACTURES, SPONTANEOUS; HIP FRACTURES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SEX DISTRIBUTION; UNITED KINGDOM; YOUNG ADULT;

EID: 84962460773     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0783     Document Type: Article

References (39)

1. Maahs DM, West NA, Lawrence JM, Mayer- Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:481-497.
2. Imkampe AK, Gulliford MC. Trends in Type 1 diabetes incidence in the UK in 0- To 14-yearolds and in 15- To 34-year-olds, 1991-2008. Diabet Med 2011;28:811-814.
3. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-866.
4. Gonźalez EL, Johansson S, Wallander MA, Rodŕiguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009;63:332-336.
5. Hamann C, Kirschner S, Gunther KP, Hofbauer LC. Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 2012;8: 297-305.
6. Strotmeyer ES, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS. Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 2006;29:306-311.
7. Botolin S, McCabe LR. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 2007;148:198-205.
8. Roggen I, Gies I, Vanbesien J, Louis O, De Schepper J. Trabecular bone mineral density and bone geometry of the distal radius at completion of pubertal growth in childhood type 1 diabetes. Horm Res Paediatr 2013;79:68-74.
9. Pater A, Sypniewska G, Pilecki O. Biochemical markers of bone cell activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2010;23:81-86.
10. Motyl K, McCabe LR. Streptozotocin, type I diabetes severity and bone. Biol Proced Online 2009;11:296-315.
11. Abd El Dayem SM, El-Shehaby AM, Abd El Gafar A, Fawzy A, Salama H. Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients. Scand J Clin Lab Invest 2011;71:387-393.
12. Nicodemus KK, Folsom AR; Iowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001;24:1192-1197.
13. Miao J, Brismar K, Nyrén O, Ugarph- Morawski A, Ye W. Elevated hip fracture risk in type 1 diabetic patients: A population-based cohort study in Sweden. Diabetes Care 2005;28: 2850-2855.
14. Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005;48:1292-1299.
15. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007;166:495-505.
16. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 2007;18:427-444.
17. Hothersall EJ, Livingstone SJ, Looker HC, et al. Contemporary risk of hip fracture in type 1 and type 2 diabetes: A national registry study from Scotland. J Bone Miner Res 2014;29:1054-1060.
18. Liao CC, Lin CS, Shih CC, et al. Increased risk of fracture and postfracture adverse events in patients with diabetes: Two nationwide population- based retrospective cohort studies. Diabetes Care 2014;37:2246-2252.
19. Forśen L, Meyer HE, Midthjell K, Edna TH. Diabetes mellitus and the incidence of hip fracture: Results from the Nord-Trøndelag Health Survey. Diabetologia 1999;42:920-925.
20. Martin-Merino E, Fortuny J, Rivero E, Garćia-Rodŕiguez LA. Validation of diabetic retinopathy and maculopathy diagnoses recorded in a U.K. primary care database. Diabetes Care 2012;35:762-767.
21. Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y. Diuretic initiation and the acute risk of hip fracture. Osteoporos Int 2013;24:689-695.
22. Schelleman H, Pollard JR, Newcomb C, et al. Exposure to CYP3A4-inducing and CYP3A4-noninducing antiepileptic agents and the risk of fractures. Pharmacoepidemiol Drug Saf 2011; 20:619-625.
23. Denburg MR, Leonard MB, Haynes K, et al. Risk of fracture in urolithiasis: A populationbased cohort study using the health improvement network. Clin J Am Soc Nephrol 2014;9: 2133-2140.
24. THIN Data Statistics [article online], 2014. Available from http://csdmruk.cegedim.com/Accessed 8 August 2014.
25. Chisholm J. The Read clinical classification. BMJ 1990;300:1092.
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999;130:461-470.
27. Bell S, Fletcher EH, Brady I, et al. End-stage renal disease and survival in people with diabetes: A national database linkage study. QJM 2015;108:127-134.
28. Toppe C, Mollsten A, Schon S, Jonsson A, Dahlquist G. Renal replacement therapy due to type 1 diabetes; time trends during 1995-2010- A Swedish population based register study. J Diabetes Complications 2014;28:152-155.
29. Diabetes UK. Diabetes in the UK 2011/2012 [article online], 2012. Available from http://www.diabetes.org.uk/documents/reports/diabetes-in-the-uk-2011-12.pdf. Accessed 24 March 2014.
30. Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment non-compliance on mortality in people with type 1 diabetes. J Diabetes Complications 2013;27:219-223.
31. Baxter-Jones AD, Faulkner RA, Forwood MR, Mirwald RL, Bailey DA. Bone mineral accrual from 8 to 30 years of age: An estimation of peak bone mass. J Bone Miner Res 2011;26: 1729-1739.
32. Tsampalieros A, Gupta P, Denburg MR, et al. Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res 2013;28:480-488.
33. American Diabetes Association. (11) Children and adolescents. Diabetes Care 2015; 38(Suppl.1):S70-S76.
34. Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T. Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care 2008;31:1729-1735.
35. Thrailkill K, Bunn RC, Lumpkin C Jr, et al. Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone. J Diabetes Res 2014;2014:703589.
36. Botolin S, McCabe LR. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 2006;99:411-424.
37. Fowlkes JL, Nyman JS, Bunn RC, et al. Osteopromoting effects of insulin-like growth factor I (IGF-I) in a mouse model of type 1 diabetes. Bone 2013;57:36-40.
38. Neumann T, Lodes S, Kästner B, et al. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control. Osteoporos Int 2014;25: 1527-1533.
39. Vestergaard P, Rejnmark L, Mosekilde L. Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int 2011; 88:209-214.